Document is current
Any future updates will be listed below
-
Authors
Fernández-Eulate, Gorka
Martin, Gilles C.
Dureau, Pascal
Speeg-Spatz, Claude
Brassier, Anais
Gillard, Perrine
Bremond-Gignac, Dominique
Thouvenin, Dominique
Pagan, Cecile
Lamari, Foudil
Nadjar, Yann http://orcid.org/0000-0003-1466-6957
-
Funding
Funding for this research was provided by:
Leadiant Biosciences
- License Information
-
More Information
Article History
Received: 13 June 2022
Accepted: 7 December 2022
First Online: 13 December 2022
Declarations
:
: This study was conducted according to French legislation and authorized by the National Commission on Informatics and Liberty (no. 2211991).
: Informed consent to publish the case report was obtained from the patient with Cerebrotendinous Xanthomatosis.
: Dr Nadjar reported grants from Takeda and Orchard therapeutics and has received honoraria from Sanofi Genzyme and Orphazyme. No other disclosures were reported.
